Powered by

Arvinas To Present at the 30th Annual Piper Jaffray Healthcare Conference

Nov 20, 2018 - GlobeNewswire

NEW HAVEN, Conn., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced that John G. Houston, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27 at 8:00 a.m. ET in New York City.

A live audio webcast of the presentation will be available at www.arvinas.com on the Events pa...